Delhi HC refuses bail to man accused of producing, supplying spurious anti-cancer medicines

Published On 2024-10-04 11:26 GMT | Update On 2025-04-30 11:55 GMT

Pune Pharmacist Loses Rs 95 Lakh in Medical Store Deal

New Delhi: The Delhi High Court has denied bail to a man accused of being the kingpin behind the production and distribution of spurious anti-cancer medicines, citing a high risk of evidence tampering..

The court said since the injections, being allegedly sold by the man, had low and compromised efficacy, there were chances that the patients to whom these injections were given could have progression or relapse of cancer which could also cause their death.

“The primary reason as to why this court granted bail to the other co-accused is that they were only pawns whereas the petitioner herein is the kingpin of the entire racket.

“The spurious injections which were primarily being manufactured by the petitioner herein and were being sold in the market have been found to be of sub-standard quality and are harmful for use,” Justice Subramonium Prasad said.

As per PTI, the court said petitioner accused Viphil Jain, who has experience in the field of pharmacy, was well aware of his act and was wilfully involved in this “life threatening and ill-perceived business” and releasing him at this juncture could result in tampering of evidence.

According to the prosecution, in March this year, information was received at Delhi Police Crime Branch’s office that Jain was procuring empty vials and other raw material for preparing spurious anti-cancer injections from his associate Parvez Malik.

Separate teams were formed to unearth the whole nexus and nab the culprits and since the information was about a syndicate indulged in manufacturing of spurious medicines, the Drugs Department of Delhi government was also informed and they were asked to join the team.

Jain and one other person were allegedly caught from a flat in Moti Nagar here while filling the empty vials with some liquid, prosecution said, adding that samples were taken from the spot and were sent to laboratory.

An FIR was lodged and the accused persons were arrested.

It said that raids were conducted at various other places and huge quantities of spurious anti-cancer injections, empty vials, packaging boxes, leaflets, vial rubber caps and vial aluminum caps were recovered and 12 accused persons were arrested.

The counsel for the petitioner sought bail on the ground of parity with other co-accused who have already been granted the relief.

However, the court dismissed the bail plea of Jain, saying he was the main person who was heading the racket of manufacture and supply of spurious injections and was aware of the entire network. He knows about all the persons who are involved in this network and the trail of money, it said.

“This court is of the opinion that if the petitioner is released on bail at this juncture, the likelihood of the petitioner tampering with evidence is extremely high. He has amassed good wealth by manufacturing spurious cancer injections and, therefore, if released on bail, the danger of him absconding cannot be ruled out. Looking at the qualification of the petitioner and his contacts, the chances of him repeating the offence also cannot be ruled out,” it said.

Article Source : With inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Delhi HC refuses bail to man accused of producing, supplying spurious anti-cancer medicines

Similar News

Roche Slammed for Seeking Zydus' Confidential Process for Cancer Drug Sigrima Without Meeting Patent Threshold

Ranitidine Under Cancer Cloud: CDSCO Calls for Monitoring NDMA Levels, Shelf Life Cuts

E-Pharmacy Threat Growing Unchecked: AIOCD Flags Regulatory Failure, Calls for Urgent CDSCO Action

Dr Reddys Labs invests Rs 565 crore in Russian subsidiary

Senores Pharma arm facility gets 3 USFDA observations

Lupin, Sun Pharma and 1 other recall products in US

Odisha: Huge cache of banned cough syrups seized, 3 arrested

Andhra Pradesh allots 531.77 acres of land to Laurus Labs